Cerrano, Marco
Itzykson, Raphael
Article History
First Online: 4 February 2019
Compliance with Ethical Standards
:
: Marco Cerrano declares that he has no conflict of interest.Raphael Itzykson has received research funding from Oncoethix S.A. (now Merck), Janssen and Novartis; has received consulting fees from Jazz Pharmaceuticals, Otsuka, and Karyopharm Therapeutics; has received honoraria from Bristol-Myers Squibb, Celgene, and Sanofi; and has received travel grants from Daiichi Sankyo.
: This article does not contain any studies with human or animal subjects performed by any of the authors.